Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the single-cell genome sequencing market?

The market size for single-cell genome sequencing has seen a rapid expansion in the past few years. It is projected to escalate from $2.49 billion in 2024 to $2.84 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 13.9%. The growth during the historic period was influenced by factors such as a heightened understanding of genetic heterogeneity, a surge in demand for precision medicine, an increase in cancer-related research, a surge in infectious disease prevalence, and heightened spending in healthcare.

What will be the single-cell genome sequencing market size in the future?

Anticipated swift expansion is forecasted for the single-cell genome sequencing market in the upcoming years. It’s projected to surge to $5.04 billion by 2029, realizing a compound annual growth rate (CAGR) of 15.4%. The escalate over the forecast period can be ascribed to the growing prevalence of autoimmune diseases, escalating neurological conditions, increased government programs and funding, the rising presence of contract research organizations (cros), and heightened awareness of scrna-seq’s potential. Key trends anticipated over the forecast period comprise improvements in single-cell sequencing technologies, the evolution of single-cell multi-omics technologies, joint endeavours to expedite advancements, ingenious solutions, and strategic collaborations by significant players.

Get your single-cell genome sequencing market report here!

https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report

What main drivers are fueling expansion in the single-cell genome sequencing market?

The expected rise in cancer cases is projected to fuel the expansion of the single-cell genome sequencing market. Cancer encompasses a wide range of diseases that involve abnormal cell growth and division, caused by changes in the genes that oversee cell division and maintain cellular function. With cancer being a disease marked by genetic alterations, single-cell genome sequencing can be instrumental in revealing the genetic changes in individual cancer cells. For example, the American Cancer Society, a U.S.-based organization dedicated to battling cancer, reported approximately 1.9 million fresh cancer diagnoses and 609,360 cancer-related deaths in the U.S. in 2022. By 2040, an estimated 27.5 million new cancer cases and 16.3 million cancer deaths are anticipated. Consequently, the projected rise in cancer prevalence is poised to stimulate the expansion of the single-cell genome sequencing market.

What key areas define the segmentation of the global single-cell genome sequencing market?

The single-cell genome sequencing market covered in this report is segmented –

1) By Type: Instruments, Reagents

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Quantitative Polymerase Chain Reaction (qPCR), Microarray, Multiple Displacement Amplification (MDA)

3) By Disease Area: Cancer, Immunology, Prenatal Diagnosis, Neurobiology, Microbiology, Other Disease Areas

4) By Application: Circulating Cells, Cell Differentiation Or Reprogramming, Genomic Variation, Subpopulation Characterization, Other Applications

5) By End User: Academic Research Laboratories, Biotechnology Biopharmaceutical Companies, Clinics, Other End Users

Subsegments:

1) By Instruments: Single-Cell Isolation Systems, Sequencing Platforms, Automation And Robotic Systems

2) By Reagents: Library Preparation Kits, Amplification Reagents, DNA Extraction Kits, Quality Control Reagents

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12655&type=smp

Who are the dominant players expanding their reach in the single-cell genome sequencing market?

Major companies operating in the single-cell genome sequencing market include F Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., DH Life Sciences LLC., Becton Dickinson And Company (BD), Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN GmbH, Bio-Techne Corporation, BGI Genomics Co. Ltd., Fulgent Genetics Inc., 10x Genomics Inc., Promega Corporation, Takara Bio Inc., Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc., Standard BioTools Inc., Singleron Biotechnologies, MGI Tech Co. Ltd, GENEWIZ Inc., Mission Bio Inc., Zymo Research Corporation, Menarini Silicon Biosystems SpA, Novogene Co. Ltd., RareCyte Inc., Fluxion Biosciences Inc., Single Cell Discoveries B.V., Parse Biosciences Inc., BioSpyder Technologies Inc., SeqWell Inc.

How are evolving market trends shaping single-cell genome sequencing Strategies?

Progress in technology is a growing trend within the single-cell genome sequencing market. The primary businesses in this field are working towards creating high-tech solutions to consolidate their market positions. For example, in May 2023, Mission Bio Inc., which is a single-cell multi-omics platform from the US that blends genotype and phenotype for cancer research and biomarker creation, launched Tapestri Genome Editing Solution. This all-encompassing product for genome editing analysis could prove to be a more potent tool for devising gene-edited, next-generation drugs. It accomplishes this by facilitating insights at a single-cell level, potentially impacting the efficacy and safety of drugs.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12655

Which regions are emerging as leaders in the single-cell genome sequencing market?

North America was the largest region in the single-cell genome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell genome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Cell Based Assays Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Cell Culture Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

Cell Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: